Quick Answer
Altamira Therapeutics Ltd. reported Net Income Loss of -$8.20 million for the year ending 2020.
- Altamira Therapeutics Ltd. showed a decrease of -23.6% in Net Income Loss from 2019 to 2020.
- This data is from Altamira Therapeutics Ltd.'s annual report (Form 10-K), filed with the SEC on March 31, 2021.
- XBRL data for this metric is available from 2018 to 2020 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2018 to 2020), Altamira Therapeutics Ltd.'s Net Income Loss has grown by 28.7%.
- Historical annual values: Fiscal year 2020: -$8.20 million | Fiscal year 2019: -$6.63 million | Fiscal year 2018: -$11.50 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: